IOVA
Iovance Biotherapeutics Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
I am a ex-prop trader and these are the stocks on my watchlist (12/27)
Maybe a possible IOVA Short Squeeze?
Squeeze started in IOVA half days volume in 10 minutes.
5 OTC STOCKS FOR POTENTIAL GROWTH 2024..THOUGHTS?
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
thought on IOVA looks like it wants to run to 8 bucks at an all time low 1 billion dollar marketcap
IOVA stock gains as Piper sees approval for melanoma therapy this year (NASDAQ:IOVA)
💰💰💰Good morning! #premarket #watchlist 12/5 $IOVA -JMP Securities Hematology and Oncology Summit Fireside Chat: December 7, 2022 at 11:00 a.m., $DUO $ZH -china buzz+no news, $XPEV -earnings
JCSE huge profit opportunity! Now! 3mill Free Float only!
💰Good morning! #premarket #watchlist 05/27 $DIDI -Report Chinese Auto Giant Is Considering Buying Stake , $AVDL -old news , $SEAC -executive officers compensation report, $GPS -Q1 2022 Earnings, $IOVA -data about its melanoma therapy, $PMVP - Phase1 data . Check it all in Realtime Stock Screener!
💰Good morning! #premarket #watchlist 05/27 $DIDI -Report Chinese Auto Giant Is Considering Buying Stake , $AVDL -old news , $SEAC -executive officers compensation report, $GPS -Q1 2022 Earnings, $IOVA -data about its melanoma therapy, $PMVP - Phase1 data . Check it all in Realtime Stock Screener!
💰Good morning! #premarket #watchlist 05/27 $DIDI -Report Chinese Auto Giant Is Considering Buying Stake , $AVDL -old news , $SEAC -executive officers compensation report, $GPS -Q1 2022 Earnings, $IOVA -data about its melanoma therapy, $PMVP - Phase1 data.
$IOVA and $CCL are two tickets setting up for a bullish play. CCL over $21.65 and IOVA over $20 could be decent short term swing trades. Just based on technical analysis and Support/Resistance lines.
$IOVA and $CCL are two tickets setting up for a bullish play. CCL over $21.65 and IOVA over $20 could be decent short term swing trades. Just based on technical analysis and Support/Resistance lines.
$IOVA is a potential biotech company to invest in.
$IOVA is likely a nice bounce play tomorrow
IOVA absolutely ate it today. Am I crazy for gobbling up shares at 16.70?
Mentions
I am all in IOVA since July 2025. They have crazy potential to bull run. 🚀
IOVA reported top line Non Samll Lung Cancer. That's the toughest data of all cancer . Undervalued sp
Be careful with PHIO and FEMY. IOVA is already well down from its premarket highs. Alot of people just got burned on INTS. Can expect people to be quicker to take biotech pump profits until INTS fiasco is memory-holed.
Long time $IOVA holder. I’m still waiting for something good .
Given the surge premarket, I think entry into CRBU at this price isn't too bad. Also watching IOVA for an entry because their data seemed pretty promising.
That's not even a basic pump n dump, that's a golden short-term play and diamond long-time play! I've been with IOVA over a year now so I'm happy this finally gets some attention
$IOVA Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) 26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027
Looking pretty darn good to me. IOVA's the play today https://preview.redd.it/japga6roh1zf1.png?width=1634&format=png&auto=webp&s=b77949a28da11136c4e150a9c479654822c93fe8
They released some news. $IOVA Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) https://www.stocktitan.net/news/IOVA/iovance-biotherapeutics-reports-potential-best-in-class-clinical-8m13xcl4tysm.html
Does anyone know how to ready trial info and can tell me if the IOVA news is good or not
Why is IOVA absolutely cranking this morning? Not complaining just don’t understand lol
what do we think about IOVA stock? 700m market cap, 52-week low is 1.64 and 52-week high is 12,50 - currently trading 1.97. Sure, it's biotech and risky but personally I think it's not as risky as those 15m market cap biotech stonks
IOVA is so ready for a short squeeze. I wonder why it doesn’t get more attention
I like your DD, not what I would expect for a biotech DD nor what I do to model out biotech but I like the write out. I’ve come across IOVA again recently after a few years without hearing about it. Modeled out some of the pipeline and I really like what I’m seeing ;). Fair value upwards of 5B and I didn’t even finish modeling out the whole pipeline.
I played with the ATYR dice roll. I broke even, but if I wanted to end it early, I would have been up 50% Similar with IOVA. Biotechs are basically dice rolls. By the time I probably hear anything it's too late.
I’m bagholding IOVA. I don’t know when it will recover but when it does it will be 10x from this price. Patiently waiting for the ER that shows a path to profitability.
Pray for IOVA to get insanely pumped
$IOVA first every Til Therapy for Cancer Tech and AI are way overhyped for yrs. Biotechs have neen slammed for yrs. Ought for a rotstion and correction
Can you guys pump IOVA next? I could really use some money, thanks
Thanks ChatGPT! Also IOVA has a good product, but the worst C-Suite team I’ve ever come across. Good luck, but I’m not getting burned by these mfers again.
Please, you ever play IOVA earnings? Shit is down 30-50% every call 😂
Absolutely. Bankruptcy is a possibility and that’s why I’m hesitant to put more money into IOVA…
I‘m also a bagholder and down 40%. However, I’m thinking of moving all my RKLB gains (100k) in IOVA - risky move, but the reward could be huge…
Locked in 20 3/26 IOVA 2.5 calls last week. Might fuck around and do it again
DNN and IOVA leaps were a good move me thinks
Yeah this is it. IOVA was also posted here and it is my worst play by a good margin. And the guy who made the DD deleted his account. It's tough to spot good/bad DD. Got to really pay attention, read carefully, consider the stock. And then get quite lucky. But there's good stuff here. Better than anywhere else on the net I would guess.
u/therealcyril How soon is this lung data coming? Is there any imminent medical conference IOVA are due to attend, where this data will be revealed, for example?
IOVA literally has a lawsuit pending
MYO and IOVA are set up nicely
MYO and IOVA today. I have it on good authority
MYO and IOVA today 🤌🤌
MYO and IOVA will run hard tomorrow
MYO and IOVA after hours 🤌🤌🤌. In for a good day tomorrow
MYO and IOVA will be much higher tomorrow
$IOVA. Lung data news coming soon.
Iovance Biotherapeutics is a biopharmaceutical company specializing in cell-based immunotherapies for cancer, particularly tumor-infiltrating lymphocyte (TIL) therapies. Here are the key points about what Iovance produces/develops: What is TIL therapy? Tumor-infiltrating lymphocytes are immune cells (T cells) that are found in tumors and have the potential to recognize and attack cancer cells. In this therapy, such cells are removed from a patient's tumor, multiplied ex vivo, "reinvigorated," or activated, and then reinjected into the patient. [iovance.com](http://iovance.com) This usually includes preparatory chemotherapy (lymphodepleting) and, if necessary, additional interleukin-2 (IL-2) to support the effect of the T cells. Products and Pipeline Amtagvi® (active ingredient: lifileucel) is Iovance's lead product. It is a TIL therapy for the treatment of adults with unresectable or metastatic melanoma when previous treatments with PD-1 inhibitors (and, if relevant, with BRAF inhibitors for BRAF-mutated tumors) have failed. BeyondSPX They also have Proleukin, a product with IL-2 that is used as an adjunct in therapy. [Investing.com](http://Investing.com) Other programs in the pipeline: IOV-4001: genetically modified TIL in which, for example, the checkpoint protein PD-1 is deactivated (using TALEN technology). The goal is a more effective TIL therapy for solid tumors. [iovance.com](http://iovance.com) IOV-3001: an IL-2 analog/antibody cytokine construct licensed from Novartis to enhance the IL-2 component of the regimen. [https://www.wsj.com/market-data/quotes/IOVA/research-ratings](https://www.wsj.com/market-data/quotes/IOVA/research-ratings)
Please be careful. There is a good chance their FDA meeting is delayed/pushed to next quarter due to government shutdown. Happened to me when I was playing IOVA before their approval. Delayed the catalyst for months. Also, RFK Jr. hates anti-psychotic meds and anti-depressant/SSRIs.
IOVA and DNN spread puts and calls are first order of business I think, a few other covered calls on held positions
Haha not to shabby my man nice, at least the LEU is covering the IOVA loss lol
I bought LEU at 63, CRWV at 34, UURAF at 1.23, and IOVA at 11.
Melanoma provides some downside protection - we aren't pre-revenue with IOVA. They can grow sales through melanoma alone, which they are actively working to expand into new markets (recently got Canada and Switzerland approval and are working towards EU). But the real growth driver would be lung. The market is billions higher if they can get approval for it, and would be huge for the stock price
Yeah, IOVA seems like a real “binary event” stock. If the TIL data hits, the upside could be huge, but I’m still a bit worried about execution risk. Which indication do you think is the real catalyst melanoma or lung?
IOVA has data coming by end of year see if their TIL therapy can be used for non-small cell lung cancer (NSCLC) and endometrial cancer. The therapy is already approved to treat advanced Melanoma, so it's not exactly a shot in the dark here and management seems optimistic. If the data is good, the stock will easily get back to double digits. They aren't even pre-revenue either, they are already increasing revenues from melanoma treatments Riskier play than the 3 mentioned, but much higher reward potential
You’re buying IOVA?? Or just holding?
I’ve day traded IOVA for a while. Any time it’s under $2.15 is a steal, so I loaded up today. It’s good to see it being used outside of Melanoma cases. It got on my radar when their competitor wasn’t FDA approved.
$5k on SOXL calls bought last month. Bought some more leaps on DNN, IOVA, and PSKY. I’m out. Good luck you dirty dogs
Hey any short squeeze experts (I am not!) - looking at IOVA - what about that makes or does not make it a good short squeeze candidate? Any voices of experience input appreciated from what you can glean by their stats and summary. If it is not a good short squeeze candidate, kindly offer one for comparison / contrast. Appreciate you all!
I would say $ELTP and $IOVA
BTAI and IOVA seem to have woken up over the weekend. Yessss
Hard pass for me on IOVA. Been burned before, it’s a “wait forever” type of stock
IOVA has great cancer treatment but has problems with production. They should figure that out next year.
IOVA surprisingly showing some signs of life
Still balls deep in IOVA 😫
IOVA. Too many catalyst this 2025 H2 to fail. 10x opportunity at least easy.
The bet is IOVA! Melanoma cancer...
How’re we feeling about LIDR - CAN - AREC - BJDX - PMNT - IOVA this mornin? Had some good wins this week but down on all these right now..
At least for a little bit - and/or biotech - I'm watching RIGL (hidden gem), MBOT, IOVA
CDXS, MBOT, RIGL, IOVA all bounced right back - will be interesting to watch.
Consider mixing some small cap in too if you're going to do that, not just MAG 7. Why bail on VOO then reinvest in the essentialy the top VOO holdings - what's the point? META prints money. Broadcom and Berkshire - why run? Smaller caps of interest RIGL, MBOT, IOVA. RDW and RKLB are way down with reasonable entry points with the dump. Maybe mix in some defense stocks or ETFs? But as they say - VOO and chill, not a bad way to be - zoom out and look at the long chart
Fuck it complete cash gang now. Made decent gains on IOVA today. But lost them all to be flat 😔
Will i finally break even on this IOVA bitch
IOVA sell the news AGAIN? Will we see red?
Any fellow IOVA bag holders here
It's pharma, look at SRPT and IOVA, they can always dump further.
$IOVA. Approval for use in Canada.
Looks like $IOVA went up to $3.23 overnight. Looks like very strong price targets and heavy institutional buying in Q2. Seems like this should be good for short term profit but safe mid term hold as well, no?
Where is the $IOVA guy? Is it still a play? Got Health Canada approval
I'm going for it --- $IOVA if approval in 2 major countries, potential partnerships with an approved cancer drug AND European approval on the horizon isn't a 3-4x gain, I give up.
OP deleted his account. Check out IOVA in premarket right now… we might just survive hahah
Bought some IOVA and thought I fucked myself badly, maybe being regarded has it's perks
What happened to IOVA lol
Wow am I actually about to win on biotech. Bought 50 $2.5 IOVA calls today, and also holding 6k shares, and then they announced Canada approval after the bell. I guess there's a first time for everything. 😅
Some sad paper-handed-bitch sold me IOVA for $1.8 two weeks ago.
IOVA taking off AH, up 10% and climbing.........
IOVA starting to take off AH, Canada FDA approval / expansion just announced this afternoon for melanoma cure and potential other tumor remedies. Cheap opp with room to run. Holding long here and looking forward to EU expansion and operational improvement. Long meaning hopium for \~5-10x in 2026, or sooner if buyout [https://www.morningstar.com/news/globe-newswire/9514348/iovances-amtagvi-lifileucel-receives-health-canada-approval-for-advanced-melanoma](https://www.morningstar.com/news/globe-newswire/9514348/iovances-amtagvi-lifileucel-receives-health-canada-approval-for-advanced-melanoma)
IOVA is approved by FDA for USAr. Today received approval also in Canada, expanding market opportunity. [https://www.morningstar.com/news/globe-newswire/9514348/iovances-amtagvi-lifileucel-receives-health-canada-approval-for-advanced-melanoma](https://www.morningstar.com/news/globe-newswire/9514348/iovances-amtagvi-lifileucel-receives-health-canada-approval-for-advanced-melanoma)
Why is IOVA pumping AH? Was there news or is it a regard pump?
Glad I sold my IOVA calls for dirt cheap this morning...
IOVA. Because I’m holding bags as big as air balloons and don’t feel like eating that loss. In all honesty, I think they get bought in 2 years by a bigger biotech fish which will moonshot the stock
I also put $600k USD in IOVA at $1.80
IOVA. that was my catalyst of my downfall. i aint made money since.
\> ONDS - We got killer drones before GTA VI I'm amazed how precisely these "DD" guys post their shit at the absolute top (Fuck you, IOVA guy, btw). It can't be a coincidence.
CTM, MBOT, and believe it or not, IOVA :)
here’s where my head’s at for aug/early sept (dates move, so DYOR): keeping an eye on IOBT after the topline P3 in melanoma, want to see follow-ups on durability/OS, plus any partner chatter and how they handle financing; CYTK for late-stage cardiomyopathy and how they pace the reg/launch story; VKTX across obesity/NASH where study design and tolerability matter more to me than headline hype; IMTX on TCR/T-cell durability and the exact wording around the registrational path; IOVA where it’s all about commercial execution and label expansions now; and SGMT as a mid-to-late NASH name where runway and phase-transition risk are front and center. i’ve been cleaning watchlists, re-reading protocols/SAPs, and tagging spots where label language could be the swing factor. also journaling each idea with simple if/then exits (e.g., approval + boxed warning = fade. clean label + no REMS = consider holding into early launch metrics). Not advice, just sharing how i’m approaching it. if you’re tracking other late-stage names or a weird PDUFA setup this month, drop it below and let’s sanity-check together.
IOVA has been getting murdered